Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.2.9159.3719
Address
Level 4 309 George Street Sydney, New South Wales (NSW) 2000
Description
EchoIQ Ltd. engages in the development and application of artificial intelligence for the cardiac diagnostics sector, as well as the supply of software used by the health fund and insurance sector. It operates through the Houston WeHave Software and Echo IQ segments. The Houston WeHave Software segment offers products and services across defence and other sectors. The Echo IQ segment focuses on developing artificial intelligence software that aids in predicting Aortic Stenosis heart condition. The company was founded by Richard Charles Anstey on March 31, 2010 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.1 - 0.31
Trade Value (12mth)
AU$77,068.00
1 week
-10.2%
1 month
-4.35%
YTD
29.41%
1 year
37.5%
All time high
3.03
EPS 3 yr Growth
0.90%
EBITDA Margin
%
Operating Cashflow
-$4m
Free Cash Flow Return
-55.50%
ROIC
-76.50%
Interest Coverage
N/A
Quick Ratio
1.60
Shares on Issue (Fully Dilluted)
505m
HALO Sector
Mining
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
18 December 24 |
Proposed issue of securities - EIQ
×
Proposed issue of securities - EIQ |
18 December 24 |
Proposed issue of securities - EIQ
×
Proposed issue of securities - EIQ |
18 December 24 |
Notification of cessation of securities - EIQ
×
Notification of cessation of securities - EIQ |
18 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
18 December 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
13 December 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
12 December 24 |
APPOINTMENT OF LEADING CARDIAC FOCUSSED US-BASED NED
×
APPOINTMENT OF LEADING CARDIAC FOCUSSED US-BASED NED |
11 December 24 |
mFund - Monthly Redemption Report - PML01 (PML-AU)
×
mFund - Monthly Redemption Report - PML01 (PML-AU) |
11 December 24 |
mFund - Monthly Redemption Report - PML02 (PML-AU)
×
mFund - Monthly Redemption Report - PML02 (PML-AU) |
09 December 24 |
The First Step in EIQs US Market Commercialisation Strategy
×
The First Step in EIQs US Market Commercialisation Strategy |
06 December 24 |
S&P DJI Announces December 2024 Quarterly Rebalance
×
S&P DJI Announces December 2024 Quarterly Rebalance |
18 November 24 |
EIQ signs integration agreement with Flagship US Hospital
×
EIQ signs integration agreement with Flagship US Hospital |
12 November 24 |
Results of Meeting
×
Results of Meeting |
11 November 24 |
mFund - Monthly Redemption Report - PML01 (PML-AU)
×
mFund - Monthly Redemption Report - PML01 (PML-AU) |
11 November 24 |
mFund - Monthly Redemption Report - PML02 (PML-AU)
×
mFund - Monthly Redemption Report - PML02 (PML-AU) |
07 November 24 |
Echo IQ Webinar 6 November 2024 - Recording Available
×
Echo IQ Webinar 6 November 2024 - Recording Available |
04 November 24 |
Investor Webinar
×
Investor Webinar |
01 November 24 |
Notification of cessation of securities - EIQ
×
Notification of cessation of securities - EIQ |
01 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
29 October 24 |
Notice of Annual General Meeting Resolutions
×
Notice of Annual General Meeting Resolutions |
25 October 24 |
Quarterly Activities Report and Appendix 4C Cash Flow Report
×
Quarterly Activities Report and Appendix 4C Cash Flow Report |
15 October 24 |
Response to ASX Query Letter
×
Response to ASX Query Letter |
11 October 24 |
mFund - Target Market Determination - PML01 (PML-AU)
×
mFund - Target Market Determination - PML01 (PML-AU) |
11 October 24 |
mFund - Product Disclosure Statement - PML01 (PML-AU)
×
mFund - Product Disclosure Statement - PML01 (PML-AU) |
11 October 24 |
mFund - Target Market Determination - PML02 (PML-AU)
×
mFund - Target Market Determination - PML02 (PML-AU) |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.